Cytosorbents Corp
CTSO
Revenue
6.23M
▲1.04M▲20.05%
3 Months ChangeAssets
53.43M
▲6.36M▲13.50%
3 Months ChangeLiabilities
36.69M
▲8.55M▲30.37%
3 Months ChangeFree Cash Flow
-4.87M
▼-1.26M▼-34.75%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-01
Form 8-K
ID: 0001104659-24-105024
2024-10-01
Form 8-K
ID: 0001104659-24-104669
2024-08-20
Form 8-K
ID: 0001104659-24-091315
2024-08-16
Form 8-K
ID: 0001104659-24-090567
2024-08-14
Form 8-K
ID: 0001104659-24-089068
2024-08-13
Form 10-Q
ID: 0001410578-24-001368
2024-08-01
Form 8-K
ID: 0001104659-24-084908
2024-07-05
Form 8-K
ID: 0001104659-24-077866
2024-06-10
Form 8-K
ID: 0001104659-24-070039
2024-05-22
Form 8-K
ID: 0001104659-24-064300